HemoShear Therapeutics

HemoShear Therapeutics is a clinical-stage company developing new treatments for patients with rare metabolic disorders. We leverage our deep understanding of complex diseases to discover breakthrough therapies for our proprietary pipeline. We also collaborate with biopharmaceutical companies to accelerate their drug discovery and development programs in liver disease, gout, and metabolic disorders.